Discover
KMTS
Kestra Medical Technologies, Ltd.
24.43
2 x 17.80
2 x 31.24
bid
ask
+
0.08
0.33%
2 @ 07:52 PM
24.30 -0.13 (0.53%)
| Ytd | -7.88% | |
| 1y | -3.06% |
24.30
day range
25.08
17.87
52 week range
28.35
| Open | 24.35 | Prev Close | 24.35 | Low | 24.30 | High | 25.08 | Mkt Cap | 1.46B |
| Vol | 1.25M | Avg Vol | 386.42K | EPS | -2.68 | P/E | N/A | Forward P/E | -11.89 |
| Beta | 0.62 | Short Ratio | 10.24 | Inst. Own | 101.65% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 12-14 | 50-d Avg | 25.13 | 200-d Avg | 23.50 | 1yr Est | 30.29 |
| Income Statement | |||
| Total Revenue | 30.97M | ||
| Revenues (USD) | 30.97M | ||
| Cost of Revenue | 13.47M | ||
| Gross Profit | 17.50M | ||
| Operating Expenses | 55.16M | ||
| Research and Development Expense | 6.80M | ||
| Selling, General and Administrative Expense | 48.36M | ||
| Operating Income | -37.66M | ||
| Interest Expense | 1.93M | ||
| Income Tax Expense | 50.00K | ||
| Net Income | -44.09M | ||
| Net Income Common Stock | -44.09M | ||
| Net Income Common Stock (USD) | -44.09M | ||
| Consolidated Income | -44.09M | ||
| Earnings per Basic Share | -0.75 | ||
| Earnings per Basic Share (USD) | -0.75 | ||
| Earnings per Diluted Share | -0.75 | ||
| Earning Before Interest & Taxes (EBIT) | -42.11M | ||
| Earning Before Interest & Taxes (USD) | -42.11M | ||
| Weighted Average Shares | 58.57M | ||
| Weighted Average Shares Diluted | 58.57M | ||
| Balance Sheet | |||
| Cash and Equivalents | 70.73M | ||
| Cash and Equivalents (USD) | 70.73M | ||
| Investments | 176.14M | ||
| Investments Current | 130.35M | ||
| Investments Non-Current | 45.79M | ||
| Trade and Non-Trade Receivables | 15.41M | ||
| Current Assets | 226.27M | ||
| Property, Plant & Equipment Net | 66.92M | ||
| Total Assets | 347.36M | ||
| Debt Current | 23.00K | ||
| Total Debt | 76.45M | ||
| Current Liabilities | 48.27M | ||
| Debt Non-Current | 76.42M | ||
| Total Liabilities | 125.00M | ||
| Accumulated Retained Earnings (Deficit) | -695.95M | ||
| Accumulated Other Comprehensive Income | -471.00K | ||
| Shareholders Equity | 222.36M | ||
| Shareholders Equity (USD) | 222.36M | ||
| Assets Non-Current | 121.08M | ||
| Total Debt (USD) | 76.45M | ||
| Inventory | 7.44M | ||
| Liabilities Non-Current | 76.73M | ||
| Trade and Non-Trade Payables | 25.96M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.77M | ||
| Net Cash Flow from Financing | 22.50M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -31.15M | ||
| Capital Expenditure | -8.34M | ||
| Issuance (Purchase) of Equity Shares | 2.02M | ||
| Issuance (Repayment) of Debt Securities | 21.65M | ||
| Net Cash Flow from Investing | -21.35M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -13.02M | ||
| Net Cash Flow from Operations | -32.29M | ||
| Share Based Compensation | 9.52M | ||